120 Participants Needed

Cognitive Rehabilitation for Traumatic Brain Injury

JM
DC
JV
Overseen ByJuliana V Baldo, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help Veterans with a history of mild to moderate traumatic brain injury (TBI) improve attention, memory, and emotional control, which are vital for success in daily life. It will test two remote rehabilitation approaches—BrainStrong-GSR and BrainStrong-OPT—delivered via tele-rehabilitation and supported by digital apps. Veterans who have had a TBI, experience issues like trouble with working memory, and are interested in setting personal goals and intensive training might be a good fit. This unphased trial offers Veterans the opportunity to explore innovative rehabilitation methods tailored to their needs.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it mentions that participants should not have active changes in psychotropic medications (drugs affecting mood, perception, or behavior). It's best to discuss your specific medications with the trial coordinators.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Previous studies have examined the treatments BrainStrong-GSR and BrainStrong-OPT for aiding individuals with traumatic brain injury (TBI). These treatments aim to enhance skills such as attention and memory. Research has shown that both treatments are designed to be safe and manageable.

For BrainStrong-GSR, studies have not identified any major safety concerns. This treatment improves focus and task completion. Although specific side effects are not detailed, the absence of reported issues suggests it is likely well-tolerated.

Similarly, BrainStrong-OPT seeks to enhance brain function. While research on brain injury has tested various methods, no specific evidence indicates harmful effects from BrainStrong-OPT itself. This implies it may be safe to use, though detailed safety information remains limited.

With the trial phase marked as "Not Applicable," these treatments might be considered non-invasive or low-risk. This generally indicates they are expected to be safe, but consulting a healthcare provider is essential to understand any personal risks.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments because BrainStrong-GSR and BrainStrong-OPT offer new approaches to cognitive rehabilitation for traumatic brain injury (TBI). Unlike traditional therapies like cognitive behavioral therapy or medication, BrainStrong-GSR uses Goal-directed State Regulation Training, which focuses on helping patients control their cognitive states. Meanwhile, BrainStrong-OPT aims to enhance brain functioning by optimizing neural pathways. These methods provide innovative ways to tackle TBI symptoms, potentially offering more personalized and effective rehabilitation options.

What evidence suggests that this trial's treatments could be effective for traumatic brain injury?

Research has shown that after a traumatic brain injury (TBI), the brain can heal by forming new connections, a process called neuroplasticity. In this trial, participants will join one of two treatment arms. The BrainStrong-GSR method, one treatment being tested, focuses on improving metacognitive skills, helping individuals think about their own thinking. Studies have found that this can lead to better outcomes in daily life for those with TBI. Meanwhile, the BrainStrong-OPT method, another treatment option in this trial, may enhance brain function by addressing heart-related issues linked to the severity of TBI. Both methods aim to improve goal-directed activities, which are essential for enhancing quality of life after a TBI.16789

Who Is on the Research Team?

AJ

Anthony J. W. Chen, MD MA

Principal Investigator

VA Northern California Health Care System, Mather, CA

Are You a Good Fit for This Trial?

This trial is for post-9/11 Veterans aged 21-60 who have had a mild to moderate traumatic brain injury and are at least six months into recovery. They should experience cognitive symptoms like memory issues and be interested in goal-setting and training. It's not suitable for those with severe mental health conditions, other neurological disorders, or ongoing medical issues that could affect participation.

Inclusion Criteria

I have had a mild to moderate traumatic brain injury.
I am between 21 and 60 years old and have had a mild to moderate traumatic brain injury.
I am over 6 months post-injury, have memory issues, and am open to intensive training.
See 5 more

Exclusion Criteria

Severe cognitive dysfunction (below 2 standard deviations on two composite cognitive domains)
Current medical illnesses that may alter mental status or disrupt participation in the study
Symptom magnification or malingering
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either Goal-directed State Regulation Training (GSR) or Optimization of Brain Functioning (OPT) via tele-rehabilitation, augmented by digital apps

5 weeks
Remote sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 3 months post-intervention

3 months
In-person assessments

What Are the Treatments Tested in This Trial?

Interventions

  • BrainStrong-GSR
  • BrainStrong-OPT
Trial Overview The study tests two remote rehabilitation methods delivered via tele-rehabilitation supported by digital apps: BrainStrong-OPT and BrainStrong-GSR. These interventions aim to help Veterans improve attention regulation, memory retention, and emotional control to achieve their life goals.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: BrainStrong-GSRExperimental Treatment1 Intervention
Group II: BrainStrong-OPTActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Published Research Related to This Trial

A 4-week program of nonimmersive virtual reality (VR) exercise significantly improved cognitive functions, such as attention and memory, in 13 adults with traumatic brain injury (TBI) compared to control groups.
A single session of VR exercise also led to notable improvements in reaction and movement times, suggesting that even short bouts of exercise in a virtual environment can enhance cognitive performance in TBI patients.
Improving cognitive function after brain injury: the use of exercise and virtual reality.Grealy, MA., Johnson, DA., Rushton, SK.[2022]
A pilot study involving 10 individuals with traumatic brain injury (TBI) showed that a computerized brain plasticity-based cognitive training (BPCT) program can be effectively used at home to improve cognitive functioning, with participants reporting subjective improvements and small to large effect sizes on cognitive measures.
The BPCT program was well-received, with minimal technical difficulties and only mild fatigue reported, suggesting it could serve as a beneficial adjunct to traditional neurorehabilitation for TBI patients, even years after their injury.
Feasibility of computerized brain plasticity-based cognitive training after traumatic brain injury.Lebowitz, MS., Dams-O'Connor, K., Cantor, JB.[2019]
Virtual reality driving simulation rehabilitation training (VRDSRT) was well-received by military personnel recovering from traumatic brain injury (TBI), with no reported side effects like simulation sickness.
Participants in the VRDSRT group showed significant improvements in driving performance and reduced instances of road rage and risky driving behaviors, indicating its effectiveness as a rehabilitation tool.
Driving rehabilitation for military personnel recovering from traumatic brain injury using virtual reality driving simulation: a feasibility study.Cox, DJ., Davis, M., Singh, H., et al.[2021]

Citations

Strengthening Neuro-Cognitive Skills for Success in ...This project will offer two training approaches targeting difficulties with goal-directed functioning associated with traumatic brain injury. Both approaches ...
Strategies and Outcomes for Traumatic Brain Injury RecoveryResults indicate that rehabilitation after TBI happens through neuroplasticity, which combines neural regeneration and functional reorganization.
Evaluating the Effectiveness of Treatment for Metacognition ...Metacognitive deficits can greatly reduce quality of life for individuals with TBI as functioning in this domain has been closely linked with successful ...
Functional Outcomes Over the First Year After Moderate to ...By 12 months postinjury, 142 of 271 with severe TBI (52.4%) and 54 of 72 with moderate TBI (75%) achieved favorable outcomes. Nearly 1 in 5 ...
The Outcome of Neurorehabilitation Efficacy and ...In Japan, TBI accounted for only 9.3% of 1,160,000 traffic accident injuries. However, of the 9,000 deaths in these data, 50.3% of them were in fact due to TBI ...
Traumatic Brain Injury: Oxidative Stress and Novel Anti- ...Accordingly, available research data indicate that decreased mitochondrial oxidative stress can suppress or delay the progression of TBI [95]. The first study ...
Neuroprotection strategies in traumatic brain injuryThis review delves into clinical strategies aimed at addressing the complexities of traumatic brain injury (TBI), specifically focusing on pharmaceutical ...
Innovative Insights into Traumatic Brain InjuriesIn CENTER-TBI's extensive study with 2869 patients, six serum biomarkers (GFAP, NF-L, NSE, S100B, total Tau, and UCHL1) were tested within 24 h of an injury.
Pathological Aspects of Traumatic Brain Injury: Role of ...When CsA is taken early after a severe TBI, it has an excellent activity and safety profile, and it also reduces lesion volume. CsA injection ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security